Chapter 252 |
2018 -- S 2539 AS AMENDED Enacted 07/02/2018 |
A N A C T |
RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT -- NON-OPIATE DIRECTIVE |
Introduced By: Senators Miller, Goodwin, Conley, and Paolino |
Date Introduced: March 01, 2018 |
It is enacted by the General Assembly as follows: |
SECTION 1. Chapter 21-28 of the General Laws entitled "Uniform Controlled |
Substances Act" is hereby amended by adding thereto the following section: |
21-28-3.33. Voluntary non-opiate directive form. |
(a) The department shall establish a voluntary non-opiate directive form. The form shall |
indicate to all practitioners that an individual shall not be administered or offered a prescription or |
medication order for an opiate. The form shall be posted on the department's searchable website. |
An individual may execute and file a voluntary non-opiate directive form with a practitioner |
licensed under chapter 37 of title 5 or other authority authorized by the director to accept the |
voluntary non-opiate directive form for filing. An individual may revoke the voluntary non-opiate |
directive form for any reason and may do so by written or oral means. |
(b) The department shall promulgate regulations for the implementation of the voluntary |
non-opiate directive form which that shall include, but not be limited to: |
(1) The procedures to record the voluntary non-opiate directive form in the individual's |
electronic health record and in the prescription drug monitoring program established pursuant to § |
21-28-3.18; |
(2) A standard form for the recording and transmission of the voluntary non-opiate |
directive form, which that shall include verification by a practitioner registered under chapter 37 |
of title 5 and which that shall comply with the written consent requirements of the Public Health |
Service Act, 42 U.S.C. § 290dd-2(b), and 42 CFR Part 2; provided, however, that the voluntary |
non-opiate directive form shall also provide the basic procedures necessary to revoke the |
voluntary non-opiate directive form; |
(3) The requirements for an individual to appoint a duly authorized guardian or health |
care proxy to override a previously recorded voluntary non-opiate directive form; |
(4) The procedures to ensure that any recording, sharing, or distribution of data relative to |
the voluntary non-opiate directive form complies with all state and federal confidentiality laws; |
and |
(5) Appropriate exemptions for pre-hospital emergency medical services providers and |
other medical personnel. |
(c) A written prescription that is presented at an outpatient pharmacy or a prescription |
that is electronically transmitted to an outpatient pharmacy shall be presumed to be valid for the |
purposes of this section and a pharmacist in an outpatient setting shall not be held in violation of |
this section for dispensing a controlled substance in contradiction to a voluntary non-opiate |
directive form, except upon evidence that the pharmacist acted knowingly against the voluntary |
non-opiate directive form. |
(d) No health care provider or employee of a health care provider acting in good faith |
shall be subject to criminal or civil liability or be considered to have engaged in unprofessional |
conduct for failing to offer or administer a prescription or medication order for an opiate under |
the voluntary non-opiate directive form. |
(e) No person acting as an agent pursuant to a health care proxy shall be subject to |
criminal or civil liability for making a decision under subsection (b)(3) of this section in good |
faith. |
(f) The board of medical licensure and discipline may limit, condition, or suspend the |
license of or assess fines against a licensed health care provider who recklessly or negligently |
fails to comply with a person's voluntary non-opiate directive form. |
SECTION 2. This act shall take effect upon passage. |
======== |
LC004812 |
======== |